Gaudium IVF and Women Health Limited IPO
Gaudium IVF and Women Health Limited was a mainboard IPO in the Healthcare Service Provider sector, offered at ₹75–₹79 per share to raise ₹165 crore. The issue was subscribed 7.27× overall (QIBs 1.62×, NIIs 14.05×, retail 7.6×). It listed on 27 Feb 2026 at ₹83 and closed its first day at ₹80, a listing gain of +1.6% versus the ₹79 issue price. It now trades around ₹106 (+34.0% versus the issue price).
Frequently asked questions
- How many times was the Gaudium IVF and Women Health Limited IPO subscribed?
- The Gaudium IVF and Women Health Limited IPO was subscribed 7.27× overall — 1.62× in the QIB category, 14.05× among non-institutional investors, 7.6× in retail.
- What were the Gaudium IVF and Women Health Limited IPO listing gains?
- Gaudium IVF and Women Health Limited listed on 27 Feb 2026 at ₹83, closing its first day at ₹80 — a listing gain of +1.6% versus the ₹79 issue price.
- What were the retail allotment odds for the Gaudium IVF and Women Health Limited IPO?
- Retail was subscribed 7.6×, so a single-lot application had roughly a 13.2% chance of allotment (about 1 in 8), and allotment was finalised on 25 Feb 2026.
- What was the price band and lot size of the Gaudium IVF and Women Health Limited IPO?
- The price band was ₹75–₹79 per share, with a minimum lot of 189 shares (₹14,931 at the upper band).
- Who were the registrar and lead manager for the Gaudium IVF and Women Health Limited IPO?
- Bigshare Services Private Limited was the registrar, and Sarthi Capital Advisors was the book-running lead manager.